Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Millions of people spend the duration of their work day sitting in front of a computer, but few people understand the health detriments that extensive sitting causes. When…
Will this be the way you access your medical records in the future? The Cicret Bracelet may be the next breakthrough in the tech space, allowing users to…
As infectious bugs grow stronger and more resistant to drugs, a British Government Commission Review warned that these “superbugs” could lead to as many as 10 million deaths by…
Xavier Pi-Sunyer, MD, MPH and Steven Edelman, MD discuss the differences in A1C reduction when using GLP-1 receptor agonists versus DPP-4 inhibitors. GLP-1 receptor agonists have a larger reduction in A1C…
“Adverse drug reactions are a common cause of anaesthetic-related morbidity and mortality in healthy patients. They include drug intolerance or immune-mediated reactions, including anaphylaxis. Allergic anaphylaxis has an…
Xavier Pi-Sunyer, MD, MPH describes how physicians can make the decision between whether to prescribe an injectable GLP-1 agonist treatment or an oral DPP-4 inhibitor when seeking to lower…
Xavier Pi-Sunyer, MD, MPH, discusses incretin therapy, a treatment which increases insulin secretion in type 2 diabetes patients. According to Pi-Sunyer, GLP-1 can be raised in the blood…
Ajay Verma, MD, PhD, Vice President, Translational Neurology, Biogen Inc., assesses the neurodegeneration problem that will accompany the significant increase in the elderly population. He discusses the imminent intersection…
Neil Jacobstein, Co-Chair of A.I. and Robotics, Singularity University, discusses the need for medical artificial intelligence to reduce medical errors. As a new generation of doctors begins practice, an…
Farzad Mostashari, MD, ScM, National Coordinator for Health Information Technology, U.S. Department of Health and Human Services discusses electronic health care. He explains how to make the transition…
